Benzinga - Tue, 16 Mar 2021 07:19:46 -0400
Benzinga - Fri, 05 Mar 2021 12:53:16 -0400
Benzinga - Thu, 04 Mar 2021 11:28:39 -0400
Benzinga - Tue, 23 Feb 2021 13:30:12 -0400
Benzinga - Wed, 23 Dec 2020 11:07:12 -0400
Benzinga - Fri, 18 Dec 2020 05:47:14 -0400
Benzinga - Thu, 17 Dec 2020 13:35:19 -0400
Benzinga - Thu, 17 Dec 2020 13:14:23 -0400
Benzinga - Wed, 16 Dec 2020 12:25:03 -0400
Benzinga - Thu, 03 Dec 2020 05:41:56 -0400
Benzinga - Wed, 02 Dec 2020 13:19:57 -0400
Benzinga - Tue, 01 Dec 2020 09:15:42 -0400
load more
Sector: Health Care.Industry: Biotechnology
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-09
REV
Q4 2020Est.ActualSurprise
EPS-6.060
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
COGTCogent Biosciences0.35%324M

Cogent Biosciences Company Questions & Answers

Q

How do I buy Cogent Biosciences (COGT) stock?

A

You can purchase shares of Cogent Biosciences (NASDAQ: COGT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cogent Biosciences's (COGT) main competitors?

A

Other companies in Cogent Biosciences’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Centogene (NASDAQ:CNTG) and Kezar Life Sciences (NASDAQ:KZR).

Q

What is the target price for Cogent Biosciences?

A

The latest price target for Cogent Biosciences (NASDAQ: COGT) was reported by Piper Sandler on 2020-12-23. The analyst firm set a price target for 22.00 expecting COGT to rise to within 12 months (a possible 152.58% upside). 3 analyst firms have reported ratings in the last year.

Q

How much is Cogent Biosciences (COGT) stock ?

A

The stock price for Cogent Biosciences (NASDAQ: COGT) is $8.71 last updated Thu Apr 22 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Cogent Biosciences (COGT) dividend?

A

There are no upcoming dividends for Cogent Biosciences.

Q

When is Cogent Biosciences (NASDAQ:COGT) reporting earnings?

A
Cogent Biosciences’s Q1 earnings are confirmed after-market from now on May 9, 2021.
Q

When is the upcoming split for COGT?

A

There is no upcoming split for Cogent Biosciences.